Literature DB >> 24338609

Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1.

Ho-Joong Kim1, Jin S Yeom, Yong-Gon Koh, Jee-Eun Yeo, Kyoung-Tak Kang, Young-Mi Kang, Bong-Soon Chang, Choon-Ki Lee.   

Abstract

The purpose of this study was to investigate the anti-inflammatory effect of platelet-rich plasma (PRP) with collagen matrix on human nucleus pulposus (NP) cell in response to pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1). NP cells from human disks were cultured in a monolayer and maintained in the collagen matrix prior to the addition of recombinant human IL-1 and TNF-α. After applying IL-1 and TNF-α, PRP prepared by using a commercially available platelet concentration system was added. The response was investigated using real-time PCR for mRNA expression of type II collagen, aggrecan, matrix metalloproteinase-3 (MMP-3), and cyclooxygenase-2 (COX-2). The combination of IL-1β and TNF-α led to decrease of matrix synthesis gene expression such as collagen type II and aggrecan and increase of the degradation gene expression of COX-2 and MMP-3, compared to the control. Consecutive PRP exposure significantly recovered the down-regulated gene expression of collagen type II and aggrecan and significantly reduced the increased MMP-3 and COX-2 gene expression, compared to that of control groups with pro-inflammatory cytokines. The administration of PRP with collagen matrix markedly suppressed cytokine-induced pro-inflammatory degrading enzymes and mediators in the NP cell. It also rescued gene expression concerning matrix synthesis, thereby stabilizing NP cell differentiation.
© 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  interleukin-1; nucleus pulposus cell; platelet-rich plasma; tumor necrosis factor-α

Mesh:

Substances:

Year:  2013        PMID: 24338609     DOI: 10.1002/jor.22532

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  23 in total

Review 1.  What is the preclinical evidence on platelet rich plasma and intervertebral disc degeneration?

Authors:  Matteo Formica; Luca Cavagnaro; Carlo Formica; Milena Mastrogiacomo; Marco Basso; Alberto Di Martino
Journal:  Eur Spine J       Date:  2015-08-14       Impact factor: 3.134

2.  Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Authors:  Xin Wang; Hua Wang; Hao Yang; Jun Li; Qiqing Cai; Irving M Shapiro; Makarand V Risbud
Journal:  Am J Pathol       Date:  2014-07-22       Impact factor: 4.307

3.  Intervertebral disc degenerative changes after intradiscal injection of TNF-α in a porcine model.

Authors:  Ran Kang; Haisheng Li; Kresten Rickers; Steffen Ringgaard; Lin Xie; Cody Bünger
Journal:  Eur Spine J       Date:  2015-04-08       Impact factor: 3.134

4.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

5.  Comparison effects of platelet-rich plasma on healing of infected and non-infected excision wounds by the modulation of the expression of inflammatory mediators: experimental research.

Authors:  Reza Pourkarim; Mohammad Reza Farahpour; Siamak Asri Rezaei
Journal:  Eur J Trauma Emerg Surg       Date:  2022-02-12       Impact factor: 2.374

Review 6.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

Review 7.  Biologic treatment of mild and moderate intervertebral disc degeneration.

Authors:  Elias S Vasiliadis; Spyros G Pneumaticos; Demitrios S Evangelopoulos; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2014-09-18       Impact factor: 6.354

Review 8.  Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update.

Authors:  Michael Monfett; Julian Harrison; Kwadwo Boachie-Adjei; Gregory Lutz
Journal:  Int Orthop       Date:  2016-04-12       Impact factor: 3.075

9.  [Clinical study of local injection of autologous platelet-rich plasma in treatment of diabetic foot ulcer].

Authors:  Xinyuan Qin; Jiangning Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-12-15

10.  Pro-inflammatory cytokines in cryptoglandular anal fistulas.

Authors:  R S van Onkelen; M P Gosselink; M van Meurs; M J Melief; W R Schouten; J D Laman
Journal:  Tech Coloproctol       Date:  2016-07-11       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.